Life Sciences

Formulating the future means reinvention today

The life sciences industry is formulating the future — and reinventing itself in the process.

Investor interest, technological advancements and collaborations are driving innovation. But the path to innovation is not without challenges. As they pursue drug development, growth-stage biotechs, med device companies and large pharmaceuticals alike will face financial risk, changing regulations, supply chain disruption and uncertain ROI.  

To seize new opportunities for growth while maintaining stability, life sciences companies need to capitalize on data, optimize performance, manage risk, fund growth and claim R&D tax credits to drive innovation. 

BDO’s Life Sciences consulting practice offers a full suite of tax, assurance and advisory services to help clients thrive in this evolving space. Our deep industry experience makes us a valuable catalyst for our clients’ success. Our BioProcess Technology Group (BPTG) provides pharmaceutical consulting and technical support with Chemistry, Manufacturing and Controls (CMC) across each stage of the drug development process, from pre-clinical research through commercialization. We also assist with ESG, including helping facilities become LEED certified and documenting clinical trial transparency.  

In life sciences, scientific and technological advancement creates opportunity: bringing investor interest, growth potential and competitive advantage. BDO stands ready to assist with technical development, risk management, revenue optimization and accelerating speed to market. 

How BDO Can Help

Who We Serve

We serve a broad range of life science clients at every lifecycle stage, including: 



Medical Device and Medical Technology Manufacturers 

Contract Research Organizations and Labs 

Contract Development and Manufacturing Organizations 

Meeting Sustainability Requirements for Life Sciences Companies 

It is critical for life sciences companies to stay ahead of regulatory requirements for sustainability and environmental, social, and governance (ESG) criteria. The final SEC Climate Disclosure Rule marks a significant shift in how businesses report their climate-related activities and impacts. For biotech, pharmaceutical, and medical device companies, understanding and complying with these new regulations is not just about adherence but also leading with transparency and accountability in a world increasingly focused on sustainability.

Life Sciences Trends & Topics Webcast Series

Produced and delivered by the BDO Life Sciences Industry Group

BDO’s Supply Management Academy

Unlock the Potential of Your Supply Teams

Stay current with our latest life sciences insights.

Meet Our Life Sciences Industry Leaders

Together, we thrive.

Everything we do is rooted in our core purpose to help people thrive every day. It’s not only the right business thing to do; it’s the right human thing to do. This starts by putting our people at the center of our work and extends to how we treat and value our people, our clients and our communities. With a dedication to quality and a purpose-driven culture, BDO offers a powerful choice both for clients and those seeking rewarding professional careers.